CKD Bio Corp. (063160.KS)
KRW 22500.0
(-1.96%)
KRW 22500.0
(-1.96%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 160.35 Billion | 156.04 Billion | 142.23 Billion | 124.59 Billion | 137.18 Billion | 124.51 Billion |
| Cost of Revenue | 155.34 Billion | 139.25 Billion | 128.93 Billion | 96.73 Billion | 101.01 Billion | 101.09 Billion |
| Gross Profit | 5.01 Billion | 16.78 Billion | 13.3 Billion | 27.86 Billion | 36.17 Billion | 23.41 Billion |
| Operating Expenses | 25.19 Billion | 31.6 Billion | 24.73 Billion | 20.25 Billion | 20.76 Billion | 16.41 Billion |
| Selling, General and Administrative Expenses | 12.51 Billion | 9.13 Billion | 6.94 Billion | 6.14 Billion | 5.26 Billion | 3.72 Billion |
| Research and Development Expenses | 12.68 Billion | 15.43 Billion | 11.51 Billion | 9.11 Billion | 10.7 Billion | 7.88 Billion |
| Other Expenses | - | 7.03 Billion | 6.27 Billion | 4.98 Billion | 4.79 Billion | 1.41 Billion |
| Cost and Expenses | 180.5 Billion | 170.85 Billion | 153.67 Billion | 116.99 Billion | 121.77 Billion | 117.5 Billion |
| Operating Income | -20.15 Billion | -14.77 Billion | -9.81 Billion | 7.6 Billion | 15.41 Billion | 7 Billion |
| Interest Expense | 4.98 Billion | 2.93 Billion | 1.93 Billion | 627.81 Million | 153.4 Million | 129.16 Million |
| Income Tax Expense | -4.09 Million | -1.88 Billion | -6.78 Billion | 851.97 Million | 3.37 Billion | 1.33 Billion |
| Earnings before Tax | -24.19 Billion | -18.58 Billion | -13.35 Billion | 7.05 Billion | 15.63 Billion | 9.29 Billion |
| Net Income | -24.19 Billion | -16.7 Billion | -6.57 Billion | 6.2 Billion | 12.26 Billion | 7.95 Billion |
| Earnings Per Share Basic | -4409.90 | -3044.61 | -1198.81 | 1147.30 | 2391.06 | 1477.21 |
| Earnings Per Share Diluted | -4409.90 | -3044.61 | -1198.81 | 1147.30 | 2391.06 | 1477.14 |
| Weighted Average Shares Outstanding | 5.48 Million | 5.48 Million | 5.48 Million | 5.41 Million | 5.12 Million | 5.38 Million |
| Weighted Average Shares Outstanding (Diluted) | 5.48 Million | 5.48 Million | 5.48 Million | 5.41 Million | 5.12 Million | 5.38 Million |
| Gross Margin | 0.03 | 0.11 | 0.09 | 0.22 | 0.26 | 0.19 |
| EBIT Margin | -0.01 | 0.02 | 0.05 | 0.15 | 0.19 | 0.15 |
| Profit Margin | -0.15 | -0.11 | -0.05 | 0.05 | 0.09 | 0.06 |
| EBITDA | -1.63 Billion | 2.28 Billion | 5.56 Billion | 19.86 Billion | 25.56 Billion | 15.96 Billion |
| Earnings Before Tax Margin | -0.13 | -0.09 | -0.07 | 0.06 | 0.11 | 0.06 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 43.88 Billion | 50.91 Billion | 45.53 Billion | 160.35 Billion | 35.33 Billion | 42.34 Billion |
| Cost of Revenue | - | 39.57 Billion | 36.29 Billion | 155.34 Billion | 35.23 Billion | 39.82 Billion |
| Gross Profit | 43.88 Billion | 11.34 Billion | 9.24 Billion | 5.01 Billion | 98.36 Million | 2.51 Billion |
| Operating Expenses | 41.3 Billion | 45.93 Billion | 42.34 Billion | 25.19 Billion | 5.09 Billion | -8.2 Billion |
| Selling, General and Administrative Expenses | - | 2.92 Billion | 6.05 Billion | - | 2.44 Billion | 8.2 Billion |
| Research and Development Expenses | - | 3.44 Billion | 3.25 Billion | - | 2.65 Billion | 4.78 Billion |
| Other Expenses | -41.3 Billion | -45.93 Billion | -42.34 Billion | 108.01 Million | -40.32 Billion | -16.41 Billion |
| Cost and Expenses | 41.3 Billion | 45.93 Billion | 42.34 Billion | 180.53 Billion | 40.33 Billion | 39.82 Billion |
| Operating Income | 2.57 Billion | 4.98 Billion | 3.18 Billion | -20.18 Billion | -5 Billion | -5.68 Billion |
| Interest Expense | - | - | 1.37 Billion | 4.98 Billion | 1.37 Billion | 1.26 Billion |
| Income Tax Expense | -156 Million | 262 Million | 84 Million | -4.09 Million | 1.07 Billion | -515.89 Million |
| Earnings before Tax | 129 Million | 4.66 Billion | 2.91 Billion | -24.19 Billion | -7.06 Billion | -6.91 Billion |
| Net Income | 285 Million | 4.4 Billion | 2.83 Billion | -24.19 Billion | -8.13 Billion | -6.39 Billion |
| Earnings Per Share Basic | 51.95 | 802.78 | 516.23 | - | -1483.19 | -1166.19 |
| Earnings Per Share Diluted | 51.95 | 802.78 | 516.23 | - | -1483.19 | -1166.19 |
| Weighted Average Shares Outstanding | 5.48 Million | 5.48 Million | 5.48 Million | 5.48 Million | 5.48 Million | 5.48 Million |
| Weighted Average Shares Outstanding (Diluted) | 5.48 Million | 5.48 Million | 5.48 Million | 5.48 Million | 5.48 Million | 5.48 Million |
| Gross Margin | 1.00 | 0.22 | 0.20 | 0.03 | 0.00 | 0.06 |
| EBIT Margin | 0.06 | 0.10 | 0.07 | - | -0.02 | 0.06 |
| Profit Margin | 0.01 | 0.09 | 0.06 | -0.15 | -0.23 | -0.15 |
| EBITDA | 2.57 Billion | 4.98 Billion | 3.18 Billion | - | -604.45 Million | 2.51 Billion |
| Earnings Before Tax Margin | 0.06 | 0.10 | 0.07 | -0.13 | -0.14 | -0.13 |
7765
NEELKANTH
CBWTF
J85
002638
RAJPALAYAM